Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy

Published:2017-12 Issue: Volume:114 Page:70-78
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Shen Jie,Ye Yuanqing,Chang David W.,Huang Maosheng,Heymach John V.,Roth Jack A.,Wu Xifeng,Zhao Hua

Funder

National Cancer Institute

MD Anderson institutional support for Center for Translational and Public Health Genomics

Duncan Family Institute for Cancer Prevention and Risk Assessment

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference47 articles.

1. Treatment of advanced squamous cell carcinoma of the lung: a review;Derman;Transl. Lung Cancer Res.,2015

2. Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer;Puchades-Carrasco;Oncotarget,2016

3. Non-small-cell lung cancer: treatment of late stage disease: chemotherapeutics and new frontiers;Scheff;Semin. Intervent. Radiol.,2013

4. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy;Cho;Surg. Oncol.,2015

5. LRIG and cancer prognosis;Lindquist;Acta Oncol.,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics for searching validated biomarkers in cancer studies: a decade in review;Expert Review of Molecular Diagnostics;2024-06-21

2. Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts;Molecular Cancer Therapeutics;2024-02-12

3. Impact of Different Treatment Regimens and Timeframes in the Plasmatic Metabolic Profiling of Patients with Lung Adenocarcinoma;Metabolites;2023-11-30

4. Prognostic Implication of Plasma Metabolites in Gastric Cancer;International Journal of Molecular Sciences;2023-08-14

5. Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma;Rapid Communications in Mass Spectrometry;2023-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3